Delivery Order SPE2DB20D2104-SPE2DB22FT35Z
Award Date 7/21/22
Potential Completion Date 7/22/22
Potential Value $52K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $21,341.03 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 5, 2022, with a completion date of July 6, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC enables Amerisourcebergen to efficiently supply a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $71,902.18 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 21, 2023. The contract has an ultimate completion date of November 22, 2023 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,340.36 and a performance period ending on July 21, 2022. The contract does not have a set-aside designation, indicating it was awarded...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has a ceiling value of $5,609.89 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,249.47, is a firm fixed-price delivery order with a completion date of November 8, 2022. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The contract has a ceiling value of $7,601.93 and is a firm fixed-price delivery order. It was awarded on January 26, 2022, with a completion date of January 27, 2022. The contract does not have a set-aside...
- The federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price valued at $14,885.12 and has a period of performance ending on September 2, 2021. The award is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award is for the delivery of Myrbetriq ER 50 MG tablets to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $13,055.29. It is a Firm Fixed Price Delivery Order with a completion date of May 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $33,043.58 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 7, 2024, with an ultimate completion date of August 8, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop...